Found: 86
Select item for more details and to access through your institution.
Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01441-8
- By:
- Publication type:
- Article
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
The neuropathological landscape of small vessel disease and Lewy pathology in a cohort of Hispanic and non-Hispanic White decedents with Alzheimer disease.
- Published in:
- Acta Neuropathologica Communications, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40478-024-01773-4
- By:
- Publication type:
- Article
Transcranial blood-brain barrier opening in Alzheimer's disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping.
- Published in:
- Theranostics, 2024, v. 14, n. 11, p. 4519, doi. 10.7150/thno.94206
- By:
- Publication type:
- Article
Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01441-8
- By:
- Publication type:
- Article
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 4, p. 2698, doi. 10.1002/alz.13735
- By:
- Publication type:
- Article
Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi‐ethnic Washington Heights–Hamilton Heights–Inwood Columbia Aging Project (WHICAP) cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 3, p. 1988, doi. 10.1002/alz.13652
- By:
- Publication type:
- Article
Data‐Independent Acquisition and Label‐Free Quantification for Quantitative Proteomics Analysis of Human Cerebrospinal Fluid.
- Published in:
- Current Protocols, 2024, v. 4, n. 3, p. 1, doi. 10.1002/cpz1.1014
- By:
- Publication type:
- Article
ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 1, p. 549, doi. 10.1002/alz.13398
- By:
- Publication type:
- Article
Identification of Hippocampal and Amygdala Subfields Predictive of MoCA Scores in Patients with Dementia with Lewy Bodies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082764
- By:
- Publication type:
- Article
Examination of Genetic Risk Factors for Alzheimer's Disease in a Cohort of Familial Longevity: the Long Life Family Study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082363
- By:
- Publication type:
- Article
Exposomics for Characterization of Environmental Drivers of AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077827
- By:
- Publication type:
- Article
Biomarker collection from the Caribbean Hispanic families from Dominican Republic and New York.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 22, p. 1, doi. 10.1002/alz.074856
- By:
- Publication type:
- Article
Stable Isotope Labelling Kinetics: Models and methods to evaluate APP production rates with Posiphen treatment in the DISCOVER clinical trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.077287
- By:
- Publication type:
- Article
ATN Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies: Initial Results from the United States Dementia with Lewy Bodies Consortium.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.077443
- By:
- Publication type:
- Article
Nutrient intake in relation to longitudinal change of blood‐based biomarkers of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079125
- By:
- Publication type:
- Article
Metabolites correlate with plasma biomarkers and clinical diagnosis of Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078516
- By:
- Publication type:
- Article
Challenges of recruitment and biomarkers collection in Caribbean Hispanics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078371
- By:
- Publication type:
- Article
Plasma‐based biomarkers of Alzheimer's Disease in a multi‐ethnic population: A Cross‐Sectional analysis from the WHICAP Study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080443
- By:
- Publication type:
- Article
Longitudinal change of plasma biomarkers with incident mild cognitive impairment or Alzheimer's disease in a multi‐ethnic cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080615
- By:
- Publication type:
- Article
Use of α‐synuclein seed amplification assays to assess how clinical features relate to the diagnosis of Dementia with Lewy Bodies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078103
- By:
- Publication type:
- Article
Learning slopes in early‐onset Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S19, doi. 10.1002/alz.13159
- By:
- Publication type:
- Article
Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 3, p. 460, doi. 10.1111/bjh.19036
- By:
- Publication type:
- Article
The neuropathological landscape of Hispanic and non-Hispanic White decedents with Alzheimer disease.
- Published in:
- Acta Neuropathologica Communications, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40478-023-01574-1
- By:
- Publication type:
- Article
Focused ultrasound mitigates pathology and improves spatial memory in Alzheimer's mice and patients.
- Published in:
- Theranostics, 2023, v. 13, n. 12, p. 4102, doi. 10.7150/thno.79898
- By:
- Publication type:
- Article
Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic Ethnicity.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e238214, doi. 10.1001/jamanetworkopen.2023.8214
- By:
- Publication type:
- Article
ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2023, v. 9, n. 1, p. 1, doi. 10.1002/trc2.12377
- By:
- Publication type:
- Article
Neuropathological autopsy findings in an individual with Alzheimer's disease who received long‐term treatment with lecanemab (BAN2401).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.069220
- By:
- Publication type:
- Article
Differential properties of Early vs. Late 18F‐Florbetaben imaging acquisition time frames.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.067766
- By:
- Publication type:
- Article
Differential properties of Early vs. Late 18F‐Florbetaben imaging acquisition time frames.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, p. 1, doi. 10.1002/alz.067820
- By:
- Publication type:
- Article
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 11, p. 1113, doi. 10.1001/jamaneurol.2022.2909
- By:
- Publication type:
- Article
Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 5, p. 756, doi. 10.1002/acn3.51529
- By:
- Publication type:
- Article
Patterns of tau pathology identified with <sup>18</sup>F‐MK‐6240 PET imaging.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 2, p. 272, doi. 10.1002/alz.12384
- By:
- Publication type:
- Article
Plasma and CSF biomarkers for Alzheimer's disease among Caribbean Hispanics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057653
- By:
- Publication type:
- Article
The impact of cerebrovascular disease on blood‐based biomarkers of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055434
- By:
- Publication type:
- Article
Plasma p‐tau181, p‐tau217, and other blood‐based Alzheimer's disease biomarkers in a multi‐ethnic, community study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 8, p. 1353, doi. 10.1002/alz.12301
- By:
- Publication type:
- Article
Sex‐associated differences in pathology burden in early‐onset Alzheimer's disease: Neuroimaging: Sex and ethnoracial differences – Biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046532
- By:
- Publication type:
- Article
Plasma biomarkers Aβ42, Aβ40, and tau in Down syndrome dementia: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045698
- By:
- Publication type:
- Article
Tau and other proteins found in Alzheimer's disease spinal fluid are linked to retromer-mediated endosomal traffic in mice and humans.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 571, p. 1, doi. 10.1126/scitranslmed.aba6334
- By:
- Publication type:
- Article
Leukocyte Telomere Length Is Unrelated to Cognitive Performance Among Non-Demented and Demented Persons: An Examination of Long Life Family Study Participants.
- Published in:
- Journal of the International Neuropsychological Society, 2020, v. 26, n. 9, p. 906, doi. 10.1017/S1355617720000363
- By:
- Publication type:
- Article
Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies.
- Published in:
- Acta Neuropathologica Communications, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40478-020-0879-z
- By:
- Publication type:
- Article
P4‐281: DOES ACQUISITION TIME AFFECT THE RESULTS OF 18F‐FLORBETABEN IMAGING?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1392, doi. 10.1016/j.jalz.2019.06.3950
- By:
- Publication type:
- Article
O3‐11‐04: AGE‐ANCHORING SCD TO OPTIMIZE ITS ASSOCIATION WITH CSF AD BIOMARKERS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P912, doi. 10.1016/j.jalz.2019.06.4687
- By:
- Publication type:
- Article
P1‐349: ADVANCING CLINICAL AND BIOMARKER RESEARCH IN AD: THE LEAD STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P383, doi. 10.1016/j.jalz.2019.06.904
- By:
- Publication type:
- Article
IC‐P‐011: DOES ACQUISITION TIME AFFECT THE RESULTS OF 18F‐FLORBETABEN IMAGING?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P20, doi. 10.1016/j.jalz.2019.06.4173
- By:
- Publication type:
- Article
O5‐03‐04: THE LEWY BODY DEMENTIA ASSOCIATION RESEARCH CENTERS OF EXCELLENCE PROGRAM: TOWARD OPTIMIZING CLINICAL CARE AND CLINICAL TRIAL INFRASTRUCTURE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1646, doi. 10.1016/j.jalz.2018.06.3010
- By:
- Publication type:
- Article
P4‐073: IN ABSENCE OF DEMENTIA, COGNITIVE PERFORMANCE DOES NOT RELATE TO THE BIOMARKER OF LEUKOCYTE TELOMERE LENGTH: AN EXAMINATION OF LONG LIFE FAMILY STUDY PARTICIPANTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1462, doi. 10.1016/j.jalz.2018.06.2476
- By:
- Publication type:
- Article
P3‐145: TELOMERE LENGTH IN HUMAN LEUKOCYTE SUBPOPULATIONS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1123, doi. 10.1016/j.jalz.2018.06.1502
- By:
- Publication type:
- Article
Gene Therapy in Alzheimer Disease—It May Be Feasible, but Will It Be Beneficial?
- Published in:
- JAMA Neurology, 2018, v. 75, n. 7, p. 791, doi. 10.1001/jamaneurol.2017.4029
- By:
- Publication type:
- Article
Frequency of GBA Variants in Autopsy-proven Multiple System Atrophy.
- Published in:
- Movement Disorders Clinical Practice, 2017, v. 4, n. 4, p. 574, doi. 10.1002/mdc3.12481
- By:
- Publication type:
- Article